2020
DOI: 10.1186/s12934-020-01425-x
|View full text |Cite
|
Sign up to set email alerts
|

Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications

Abstract: Background Inclusion bodies (IBs) are biologically active protein aggregates forming natural nanoparticles with a high stability and a slow-release behavior. Because of their nature, IBs have been explored to be used as biocatalysts, in tissue engineering, and also for human and animal therapies. To improve the production and biological efficiency of this nanomaterial, a wide range of aggregation tags have been evaluated. However, so far, the presence in the IBs of bacterial impurities such as lip… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 43 publications
(34 reference statements)
0
6
0
Order By: Relevance
“…In general, the active inclusion bodies can achieve significant increases in thermostability and reusability. However, the catalytic efficiency, like most immobilized enzymes, is lower than that of the free ones …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In general, the active inclusion bodies can achieve significant increases in thermostability and reusability. However, the catalytic efficiency, like most immobilized enzymes, is lower than that of the free ones …”
Section: Introductionmentioning
confidence: 99%
“…However, the catalytic efficiency, like most immobilized enzymes, is lower than that of the free ones. 18 The third obstacle is the relatively poor catalytic performances (for example, low efficiency at high temperatures) of CA. Currently, engineering of CAs is a common approach to cope with this problem, among which the most representative are site-specific mutations and directed evolution.…”
Section: ■ Introductionmentioning
confidence: 99%
“…This strategy has been applied in wound healing [ 30 ], for subcutaneous [ 31 ] or intranasal delivery of antigens [ 32 , 33 ], or for the local [ 34 ] or remote [ 35 ] delivery of antitumoral proteins, namely pro-apoptotic factors or tumor-targeted microbial toxins, respectively. In veterinary medicine, they have been proved as excellent immunomodulators and nanostructured vaccines [ 32 , 36 , 37 , 38 , 39 , 40 ], since minor amounts of bacterial cell wall lipopolysaccharides from the producing bacterial cells, associated to these protein granules, probably have a positive role on the immunoprotection reached [ 41 ].…”
Section: Introductionmentioning
confidence: 99%
“…After 8 h of induction with the three different inducers, we observed a downshift of the band at ~ 1639 cm −1 to ~ 1634 cm −1 , accompanied by an increase in the intensity of the band at ~ 1694 cm −1 . These spectral features, typical of GFP [ 44 ], indicate that the three different inducers cause GFP overexpression. To study its production kinetics, we therefore followed the ratio of the band at 1634 cm −1 (β-sheet) to that at ~ 1658 cm −1 (α-helix/random coil) as a function of induction times (Fig.…”
Section: Resultsmentioning
confidence: 99%